<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2025-15-5-376-382</article-id><article-id custom-type="edn" pub-id-type="custom">RZFSUD</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-2082</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РАЗБОР КЛИНИЧЕСКИХ СЛУЧАЕВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ANALYSIS OF CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Легкое течение геморрагической лихорадки с почечным синдромом у пациентки со спондилоартритом, ассоциированным с HLA-B27</article-title><trans-title-group xml:lang="en"><trans-title>Mild Course of Hemorrhagic Fever with Renal Syndrome in A Patient with HLA-B27 Positive-Spondylarthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-9738-7447</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маршала</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Marshala</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маршала Сергей Николаевич — руководитель центра персонифицированной Медицины; врач-терапевт, ревматолог, ассистент кафедры пропедевтики внутренних болезней № 2 Института клинической медицины</p><p>Москва</p></bio><bio xml:lang="en"><p>Sergey N. Marshala — MD, Head of the «Medsi group» Joint Stock Company, Center for Personalized Medicine on Michurinsky Prospekt, internist, rheumatologist, assistant of the Department of Propaedeutics of Internal Diseases № 2 of the Institute of Clinical Medicine </p><p>Moscow</p></bio><email xlink:type="simple">marshala_2011@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-4580-8851</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яровой</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Iarovoi</surname><given-names>M. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яровой Максим Дмитриевич — студент 5 курса лечебного факультета </p><p>Москва</p></bio><bio xml:lang="en"><p>Maksim D. Iarovoi — a 5th year student of the Federal State Autonomous Educational Institution of Higher Education</p><p>Moscow</p></bio><email xlink:type="simple">jarovojmax@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3853-4792</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернобровкина</surname><given-names>Т. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernobrovkina</surname><given-names>T. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чернобровкина Татьяна Яковлевна — к.м.н., врач высшей категории, доцент кафедры инфекционных болезней и эпидемиологии Института клинической медицины; врач ультразвуковой диагностики</p><p>Москва</p></bio><bio xml:lang="en"><p>Tatiana Ya. Chernobrovkina — cмs, Associate Professor of the department of infectious diseases and epidemiology of the Institute of Clinical Medicine</p><p>Moscow</p></bio><email xlink:type="simple">tychernobr@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3246-7337</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенякин</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenyakin</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенякин Игорь Владимирович — д.м.н., профессор, медицинский директор</p><p>Москва</p></bio><bio xml:lang="en"><p>Igor V. Semeniakin — MD, PhD, professor, Medical Director</p><p>Moscow</p></bio><email xlink:type="simple">semeniakin.iv@medsigroup.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7479-418X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Резник</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Reznik</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Резник Елена Владимировна — д.м.н., доцент, заведующий кафедрой пропедевтики внутренних болезней № 2 Института клинической медицины; врач-терапевт, кардиолог, врач функциональной диагностики, ультразвуковой диагностики, клинический фармаколог</p><p>Москва</p></bio><bio xml:lang="en"><p>Reznik Elena Vladimirovna — MD, PhD, Head of the Department of Internal disease Propedeutics № 2 of Institute of Clinical Medicine; Cardiologist </p><p>Moscow</p></bio><email xlink:type="simple">elenaresnik@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России (Пироговский Университет); Акционерное общество «Группа Компаний МЕДСИ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University; «Medsi group» Joint Stock Company</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России (Пироговский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Акционерное общество «Группа Компаний МЕДСИ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>«Medsi group» Joint Stock Company</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России (Пироговский Университет); Акционерное общество «Группа Компаний МЕДСИ»; ГБУЗ «ГКБ № 31 имени академика Г.М. Савельевой ДЗМ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University; «Medsi group» Joint Stock Company; City Clinical Hospital № 31 n.a. G.M. Savelieva of the Moscow Health Department</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>09</month><year>2025</year></pub-date><volume>15</volume><issue>5</issue><fpage>376</fpage><lpage>382</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Маршала С.Н., Яровой М.Д., Чернобровкина Т.Я., Семенякин И.В., Резник Е.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Маршала С.Н., Яровой М.Д., Чернобровкина Т.Я., Семенякин И.В., Резник Е.В.</copyright-holder><copyright-holder xml:lang="en">Marshala S.N., Iarovoi M.D., Chernobrovkina T.Y., Semenyakin I.V., Reznik E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/2082">https://www.medarhive.ru/jour/article/view/2082</self-uri><abstract><p>Геморрагическая лихорадка с почечным синдромом (ГЛПС) — острое инфекционное заболевание вирусной этиологии, главным осложнением которого является тяжелое поражени е почек. Для заболевания характерно цикличное течение, выделяют 4 периода (лихорадочный, олигурический, полиурический, реконвалесценция). На территории России заболевание встречается практически повсеместно, однако эндемичными районами является Дальний Восток, Урал, Поволжье. В патогенезе заболевания наибольшее значение имеет развитие поражения эндотелия сосудов, где происходит репродукция вируса, что ведет к повышению проницаемости сосудистой стенки с развитием геморрагического синдрома, отеков. Кроме того, кровоизлияниям способствует снижение факторов коагуляции, а также тромбоцитов. В литературе описаны случаи легкого течения этого заболевания у пациентов-носителей аллеля human leukocyte antigen (HLA)-B27. Целью нашей статьи является демонстрация клинического случая легкого течения ГЛПС у пациентки со спондилоартритом, ассоциированным с HLA-B27. Пациентка имела длительный субфебрилитет, а также лимфаденопатию пахового лимфоузла. Заболевание протекало без поражения почек, развития геморрагического синдрома, которые являются характерными проявлениями ГЛПС. Выявленные IgG и IgM к хантавирусам (возбудителям ГЛПС) подтвердили диагноз. Пациентка имела спондилоартрит, ассоциированный с HLA-B27, наличие которого, по данным литературы, может сделать клиническую картину менее яркой, что и наблюдается в нашем случае. В результате патогенетического лечения глюкокортикоидами достигнут регресс жалоб и улучшение состояния пациентки. Данная статья будет полезна специалистам разных профилей, так как клиническая картина ГЛПС имеет множество неспецифических симптомов, которые могут быть расценены, как проявления различных заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>Hemorrhagic fever with renal syndrome (HFRS) is an acute infectious disease of viral etiology, the main complication of which is severe kidney damage. The disease is characterized by a cyclic course, there are 4 periods (febrile, oliguric, polyuric, recollection). In Russia, the disease occurs almost everywhere, but endemic areas are the Far East, the Urals, and the Volga region. In the pathogenesis of the disease, the greatest significance is the development of vascular endothelial damage, where virus reproduction occurs, leading to increased permeability of the vascular wall with the development of hemorrhagic syndrome, edema. In addition, hemorrhages are promoted by a decrease in coagulation factors, as well as platelets. Cases of mild course of this disease in patients carrying the human leukocyte antigen (HLA)-B27 allele have been described in the literature. The aim of our article is to demonstrate a clinical case of mild course of HFRS in a patient with spondyloarthritis associated with HLA-B27. The patient presented with prolonged subfebrileitis as well as inguinal lymphadenopathy. The disease proceeded without kidney damage, development of hemorrhagic syndrome, which are characteristic manifestations of HFRS. Detected IgG and IgM to hantaviruses (causative agents of HFRS) confirmed the diagnosis. The patient had spondyloarthritis associated with HLA-B27, which, according to the literature, can make the clinical picture less vivid, which is observed in our case. Pathogenetic treatment with glucocorticoids resulted in regression of complaints and improvement of the patient’s condition. This article will be useful for specialists of different profiles, as the clinical picture of HFRS has many nonspecific symptoms that can be considered as manifestations of various diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>геморрагическая лихорадка с почечным синдромом</kwd><kwd>спондилоартрит</kwd><kwd>HLA-B27</kwd><kwd>хантавирус</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hemorrhagic fever with renal syndrome</kwd><kwd>spondyloarthritis</kwd><kwd>HLA-B27</kwd><kwd>hantavirus</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы заявляют об отсутствии финансирования при проведении исследования.</funding-statement><funding-statement xml:lang="en">The authors declare no funding for this study.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Морозов В.Г., Ишмухаметов А.А., Дзагурова Т.К. и др. Клинические особенности геморрагической лихорадки с почечным синдромом в России. Медицинский Совет. 2017;(5):156-161. https://doi.org/10.21518/2079-701X-2017-5-156-161.</mixed-citation><mixed-citation xml:lang="en">Morozov V.G., Ishmukhametov A.A., Dzagurova T.K. et al. Clinical manifestations of hemorrhagic fever with renal syndrome in Russia. Meditsinskiy sovet = Medical Council. 2017;(5):156-161 [In Russian]. https://doi.org/10.21518/2079-701X-2017-5-156-161</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов М.Ф. Геморрагическая лихорадка с почечным синдромом как социально значимая природно-очаговая инфекция. Международный научно-исследовательский журнал. 2023; 3(129). DOI: 10.23670/IRJ.2023.129.6.</mixed-citation><mixed-citation xml:lang="en">. Ivanov M.F. Haemorrhagic fever with renal syndrome as a socially significant naturally occurring infection. International Research Journal. 3(129), Mar. 2023. (In Russ.). DOI: 10.23670/IRJ.2023.129.6.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бородина Ж.И., Царенко О.Е., Монахов К.М. и др. Геморрагическая лихорадка с почечным синдромом — проблема современности. Архивъ внутренней медицины. 2019; 9(6): 419-427. DOI: 10.20514/2226-6704-2019-9-6-419-427.</mixed-citation><mixed-citation xml:lang="en">Borodina Zh.I., Tsarenko O.Ye., Monakhov K.M. et al. Hemorrhagic fever with renal syndrome: the challenge of our time. The Russian Archives of Internal Medicine. 2019; 9(6): 419-427. [In Russian]. DOI: 10.20514/2226-6704-2019-9-6-419-427.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Noh JY, Jung J, Song JW. Hemorrhagic Fever with Renal Syndrome. Infect Chemother. 2019 Dec;51(4):405-413. doi: 10.3947/ic.2019.51.4.405. Epub 2019 Oct 31. Erratum in: Infect Chemother. 2020 Jun;52(2):305-306. doi: 10.3947/ic.2020.52.2.305.</mixed-citation><mixed-citation xml:lang="en">Noh JY, Jung J, Song JW. Hemorrhagic Fever with Renal Syndrome. Infect Chemother. 2019 Dec;51(4):405-413. doi: 10.3947/ic.2019.51.4.405. Epub 2019 Oct 31. Erratum in: Infect Chemother. 2020 Jun;52(2):305-306. doi: 10.3947/ic.2020.52.2.305.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lupuşoru G, Lupuşoru M, Ailincăi I et al. Hanta hemorrhagic fever with renal syndrome: A pathology in whose diagnosis kidney biopsy plays a major role (Review). Exp Ther Med. 2021 Sep;22(3):984. doi: 10.3892/etm.2021.10416.</mixed-citation><mixed-citation xml:lang="en">Lupuşoru G, Lupuşoru M, Ailincăi I et al. Hanta hemorrhagic fever with renal syndrome: A pathology in whose diagnosis kidney biopsy plays a major role (Review). Exp Ther Med. 2021 Sep;22(3):984. doi: 10.3892/etm.2021.10416.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sehgal A, Mehta S, Sahay K et al. Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention. Viruses. 2023 Feb 18;15(2):561. doi: 10.3390/v15020561.</mixed-citation><mixed-citation xml:lang="en">Sehgal A, Mehta S, Sahay K et al. Hemorrhagic Fever with Renal Syndrome in Asia: History, Pathogenesis, Diagnosis, Treatment, and Prevention. Viruses. 2023 Feb 18;15(2):561. doi: 10.3390/v15020561.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cho M.R., Hwang J.Y., Park H.S. Hantaan Virus Reduces the von Willebrand Factor in Human Umbilical Vein Endothelial Cells. J. Bacteriol. Virol. 2007 Dec; 4(37): 225-230. doi: 10.4167/jbv.2007.37.4.225</mixed-citation><mixed-citation xml:lang="en">Cho M.R., Hwang J.Y., Park H.S. Hantaan Virus Reduces the von Willebrand Factor in Human Umbilical Vein Endothelial Cells. J. Bacteriol. Virol. 2007 Dec; 4(37): 225-230. doi: 10.4167/jbv.2007.37.4.225</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Khaiboullina SF, Morzunov SP, St Jeor SC et al. Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner. Front Microbiol. 2016 Jul 19;7:1077. doi: 10.3389/fmicb.2016.01077.</mixed-citation><mixed-citation xml:lang="en">Khaiboullina SF, Morzunov SP, St Jeor SC et al. Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner. Front Microbiol. 2016 Jul 19;7:1077. doi: 10.3389/fmicb.2016.01077.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Outinen TK, Laine OK, Mäkelä S et al. Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients. Infect Dis (Lond). 2016 Sep;48(9):682-7. doi: 10.1080/23744235.2016.1192719.</mixed-citation><mixed-citation xml:lang="en">Outinen TK, Laine OK, Mäkelä S et al. Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients. Infect Dis (Lond). 2016 Sep;48(9):682-7. doi: 10.1080/23744235.2016.1192719.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Koskela S, Mäkelä S, Strandin T et al. Coagulopathy in Acute Puumala Hantavirus Infection. Viruses. 2021 Aug 6;13(8):1553. doi: 10.3390/v13081553.</mixed-citation><mixed-citation xml:lang="en">Koskela S, Mäkelä S, Strandin T et al. Coagulopathy in Acute Puumala Hantavirus Infection. Viruses. 2021 Aug 6;13(8):1553. doi: 10.3390/v13081553.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Plyusnin A, Hörling J, Kanerva M et al. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol. 1997 May;35(5):1090-6. doi: 10.1128/jcm.35.5.1090-1096.1997.</mixed-citation><mixed-citation xml:lang="en">Plyusnin A, Hörling J, Kanerva M et al. Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol. 1997 May;35(5):1090-6. doi: 10.1128/jcm.35.5.1090-1096.1997.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Evander M, Eriksson I, Pettersson L et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol. 2007 Aug;45(8):2491-7. doi: 10.1128/JCM.01902-06.</mixed-citation><mixed-citation xml:lang="en">Evander M, Eriksson I, Pettersson L et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol. 2007 Aug;45(8):2491-7. doi: 10.1128/JCM.01902-06.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Saksida A, Duh D, Korva M et al. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis. 2008 Mar 1;197(5):681-5. doi: 10.1086/527485.</mixed-citation><mixed-citation xml:lang="en">Saksida A, Duh D, Korva M et al. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis. 2008 Mar 1;197(5):681-5. doi: 10.1086/527485.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao R, Yang S, Koster F el al. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis. 2006 Nov 15;194(10):1403-9. doi: 10.1086/508494.</mixed-citation><mixed-citation xml:lang="en">Xiao R, Yang S, Koster F el al. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis. 2006 Nov 15;194(10):1403-9. doi: 10.1086/508494.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">International Association of Professionals in Infection Control (IAPCI). Clinical guidelines. Hemorrhagic fever with renal syndrome in adults. 2016. [Electronic resource]. URL: https://libftp.mededtech.ru/GLPS/ (date of the application 31.03.2025) [In Russian]</mixed-citation><mixed-citation xml:lang="en">International Association of Professionals in Infection Control (IAPCI). Clinical guidelines. Hemorrhagic fever with renal syndrome in adults. 2016. [Electronic resource]. URL: https://libftp.mededtech.ru/GLPS/ (date of the application 31.03.2025) [In Russian]</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Parameswaran P, Lucke M. HLA-B27 Syndromes. 2025. [Electronic resource] URL: https://www.ncbi.nlm.nih.gov/books/NBK551523/. (date of the application 29.03.2025)</mixed-citation><mixed-citation xml:lang="en">Parameswaran P, Lucke M. HLA-B27 Syndromes. 2025. [Electronic resource] URL: https://www.ncbi.nlm.nih.gov/books/NBK551523/. (date of the application 29.03.2025)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bowness P. HLA-B27. Annu Rev Immunol. 2015;33:29-48. doi: 10.1146/annurev-immunol-032414-112110.</mixed-citation><mixed-citation xml:lang="en">Bowness P. HLA-B27. Annu Rev Immunol. 2015;33:29-48. doi: 10.1146/annurev-immunol-032414-112110.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kaya S. Prognostic factors in hantavirus infections. Bulletin of microbiology. 2014 Jan;48(1):179-87. [In Turkish].</mixed-citation><mixed-citation xml:lang="en">Kaya S. Prognostic factors in hantavirus infections. Bulletin of microbiology. 2014 Jan;48(1):179-87. [In Turkish].</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Korva M, Saksida A, Kunilo S et al. HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients. Clin Vaccine Immunol. 2011 Sep;18(9):1435-40. doi: 10.1128/CVI.05187-11. Epub 2011 Jul 20.</mixed-citation><mixed-citation xml:lang="en">Korva M, Saksida A, Kunilo S et al. HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients. Clin Vaccine Immunol. 2011 Sep;18(9):1435-40. doi: 10.1128/CVI.05187-11. Epub 2011 Jul 20.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mustonen J, Partanen J, Kanerva M et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol. 1998 Mar;47(3):277-9. doi: 10.1046/j.1365-3083.1998.00302.x.</mixed-citation><mixed-citation xml:lang="en">Mustonen J, Partanen J, Kanerva M et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol. 1998 Mar;47(3):277-9. doi: 10.1046/j.1365-3083.1998.00302.x.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
